Attached files
| file | filename |
|---|---|
| S-1MEF - S-1MEF - KYTHERA BIOPHARMACEUTICALS INC | a2216942zs-1mef.htm |
| EX-5.1 - EX-5.1 - KYTHERA BIOPHARMACEUTICALS INC | a2216942zex-5_1.htm |
QuickLinks -- Click here to rapidly navigate through this document
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to use of our report dated March 26, 2013, except for Note 2 as it relates to Restatement and Basic and Dilutive Net Loss per Common Share, as to which the date is September 26, 2013, with respect to the financial statements of KYTHERA Biopharmaceuticals, Inc. included in the Amendment to the Annual Report (Form 10-K/A) for the year ended December 31, 2012, in the Registration Statement (Form S-1MEF) filed to register additional securities for an offering pursuant Rule 462(b) under the Securities Act of 1933 and related Prospectus of KYTHERA Biopharmaceuticals, Inc. for the registration of its common stock, dated October 8, 2013.
/s/ Ernst & Young LLP
Los
Angeles, California
October 8, 2013
Consent of Independent Registered Public Accounting Firm